Trial Profile
Study of impact of zostavax vaccination on T-cell accumulation and cutaneous gene expression in the skin of older humans after varicella zoster virus antigen-specific challenge
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Oct 2018
Price :
$35
*
At a glance
- Drugs Varicella zoster virus vaccine (Primary)
- Indications Herpes zoster; Varicella zoster virus infections
- Focus Therapeutic Use
- 04 Oct 2018 New trial record
- 22 Sep 2018 Results published in the Journal of Infectious Diseases